Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pneumococcal Vaccine Polyvalent market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pneumococcal Vaccine Polyvalentmarket, defines the market attractiveness level of Pneumococcal Vaccine Polyvalent market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pneumococcal Vaccine Polyvalent industry, describes the types of Pneumococcal Vaccine Polyvalent market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pneumococcal Vaccine Polyvalent market and the development prospects and opportunities of Pneumococcal Vaccine Polyvalent industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pneumococcal Vaccine Polyvalent market in Chapter 13.
By Player:
Merck & Co
Pfizer
By Type:
Prevnar 13
Pneumovax23
By End-User:
18 Years and Younger
19 to 64 Years old
65 Years and Older
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pneumococcal Vaccine Polyvalent Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pneumococcal Vaccine Polyvalent Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pneumococcal Vaccine Polyvalent Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pneumococcal Vaccine Polyvalent Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pneumococcal Vaccine Polyvalent Market Analysis and Outlook to 2022
-
7.1 Global Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
-
7.2 United States Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
-
7.3 Europe Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
-
7.4 China Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
-
7.5 Japan Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
-
7.6 India Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
-
7.7 South Korea Pneumococcal Vaccine Polyvalent Consumption (2017-2022)
8 Region and Country-wise Pneumococcal Vaccine Polyvalent Market Analysis and Outlook to 2028
-
8.1 Global Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
-
8.2 United States Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
-
8.3 Europe Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
-
8.4 China Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
-
8.5 Japan Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
-
8.6 India Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
-
8.7 South Korea Pneumococcal Vaccine Polyvalent Consumption Forecast (2022-2028)
9 Global Pneumococcal Vaccine Polyvalent Market Outlook by Types and Applications to 2022
-
9.1 Global Pneumococcal Vaccine Polyvalent Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prevnar 13 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pneumovax23 Consumption and Growth Rate (2017-2022)
-
9.2 Global Pneumococcal Vaccine Polyvalent Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global 18 Years and Younger Consumption and Growth Rate (2017-2022)
-
9.2.2 Global 19 to 64 Years old Consumption and Growth Rate (2017-2022)
-
9.2.3 Global 65 Years and Older Consumption and Growth Rate (2017-2022)
10 Global Pneumococcal Vaccine Polyvalent Market Outlook by Types and Applications to 2028
-
10.1 Global Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prevnar 13 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Pneumovax23 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global 18 Years and Younger Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global 19 to 64 Years old Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global 65 Years and Older Consumption Forecast and Growth Rate (2022-2028)
11 Global Pneumococcal Vaccine Polyvalent Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pneumococcal Vaccine Polyvalent Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pneumococcal Vaccine Polyvalent Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pneumococcal Vaccine Polyvalent Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pneumococcal Vaccine Polyvalent Market Competitive Analysis
-
14.1 Merck & Co
-
14.1.1 Merck & Co Company Details
-
14.1.2 Merck & Co Pneumococcal Vaccine Polyvalent Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Pneumococcal Vaccine Polyvalent Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Pneumococcal Vaccine Polyvalent Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Pneumococcal Vaccine Polyvalent Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pneumococcal Vaccine Polyvalent
-
Figure Pneumococcal Vaccine Polyvalent Picture
-
Table Global Pneumococcal Vaccine Polyvalent Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pneumococcal Vaccine Polyvalent Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pneumococcal Vaccine Polyvalent Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pneumococcal Vaccine Polyvalent Consumption by Country (2017-2022)
-
Figure United States Pneumococcal Vaccine Polyvalent Consumption and Growth Rate (2017-2022)
-
Table Europe Pneumococcal Vaccine Polyvalent Consumption and Growth Rate (2017-2022)
-
Figure China Pneumococcal Vaccine Polyvalent Consumption and Growth Rate (2017-2022)
-
Figure Japan Pneumococcal Vaccine Polyvalent Consumption and Growth Rate (2017-2022)
-
Figure India Pneumococcal Vaccine Polyvalent Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pneumococcal Vaccine Polyvalent Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Vaccine Polyvalent Consumption Forecast by Country (2022-2028)
-
Figure United States Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pneumococcal Vaccine Polyvalent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prevnar 13 Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumovax23 Consumption and Growth Rate (2017-2022)
-
Figure Global 18 Years and Younger Consumption and Growth Rate (2017-2022)
-
Figure Global 19 to 64 Years old Consumption and Growth Rate (2017-2022)
-
Figure Global 65 Years and Older Consumption and Growth Rate (2017-2022)
-
Figure Global Prevnar 13 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumovax23 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 18 Years and Younger Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 19 to 64 Years old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 65 Years and Older Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pneumococcal Vaccine Polyvalent Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pneumococcal Vaccine Polyvalent Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Pneumococcal Vaccine Polyvalent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Pneumococcal Vaccine Polyvalent Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pneumococcal Vaccine Polyvalent Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pneumococcal Vaccine Polyvalent Product and Service
-
